Metraipolis › archive › dc_d620d72bef5c
Validation of Madecassoside Synergy Significantly Enhanced Cryptotanshinone's Therapeutic Efficacy Against Acne Vulgaris — Europe PMC PMID:41007180
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41007180
- DOI
- 10.3390/bioengineering12090935
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T06:20:40.948Z
- SHA-256 of the archived text
e1438746f701ee4099004521716551c9d32310a8f840baf0471008e44ac1f0e1- Stable URL of this page
https://metraipolis.com/documento/dc_d620d72bef5c
How to cite
Validation of Madecassoside Synergy Significantly Enhanced Cryptotanshinone's Therapeutic Efficacy Against Acne Vulgaris — Europe PMC PMID:41007180 — Europe PMC (en), https://europepmc.org/article/MED/41007180 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d620d72bef5c (Metraipolis archive dc_d620d72bef5c, sha256 e1438746f701ee4099004521716551c9d32310a8f840baf0471008e44ac1f0e1)
BibTeX
@misc{dcd620d72bef5c,
title = {Validation of Madecassoside Synergy Significantly Enhanced Cryptotanshinone's Therapeutic Efficacy Against Acne Vulgaris — Europe PMC PMID:41007180},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41007180},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d620d72bef5c; sha256 e1438746f701ee4099004521716551c9d32310a8f840baf0471008e44ac1f0e1},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41007180. Agents can read the archived copy with the MCP tool read_document.